vs
福尼克斯（PLAB）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
福尼克斯的季度营收约是Ultragenyx Pharmaceutical Inc.的1.0倍（$210.4M vs $207.3M），福尼克斯净利率更高（10.9% vs -62.0%，领先72.9%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -5.5%），福尼克斯自由现金流更多（$25.2M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -3.8%）
福尼克斯是美国半导体光掩模制造商，2009年时位居全球第三大光掩模供应商，同时也是电子束产业倡议组织的成员，专注于为半导体行业提供关键的掩模产品，支撑芯片制造环节的图形转移需求。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
PLAB vs RARE — 直观对比
营收规模更大
PLAB
是对方的1.0倍
$207.3M
营收增速更快
RARE
高出31.4%
-5.5%
净利率更高
PLAB
高出72.9%
-62.0%
自由现金流更多
PLAB
多$126.0M
$-100.8M
两年增速更快
RARE
近两年复合增速
-3.8%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $210.4M | $207.3M |
| 净利润 | $22.9M | $-128.6M |
| 毛利率 | 33.7% | — |
| 营业利润率 | 22.9% | -54.7% |
| 净利率 | 10.9% | -62.0% |
| 营收同比 | -5.5% | 25.9% |
| 净利润同比 | -32.4% | 3.5% |
| 每股收益（稀释后） | $0.39 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PLABRARE
| Q4 25 | — | $207.3M | ||
| Q3 25 | $210.4M | $159.9M | ||
| Q2 25 | $211.0M | $166.5M | ||
| Q1 25 | $212.1M | $139.3M | ||
| Q4 24 | $222.6M | $164.6M | ||
| Q3 24 | $211.0M | $139.5M | ||
| Q2 24 | $217.0M | $147.0M | ||
| Q1 24 | $216.3M | $108.8M |
净利润PLABRARE
| Q4 25 | — | $-128.6M | ||
| Q3 25 | $22.9M | $-180.4M | ||
| Q2 25 | $8.9M | $-115.0M | ||
| Q1 25 | $42.9M | $-151.1M | ||
| Q4 24 | $33.9M | $-133.2M | ||
| Q3 24 | $34.4M | $-133.5M | ||
| Q2 24 | $36.3M | $-131.6M | ||
| Q1 24 | $26.2M | $-170.7M |
毛利率PLABRARE
| Q4 25 | — | — | ||
| Q3 25 | 33.7% | — | ||
| Q2 25 | 36.9% | — | ||
| Q1 25 | 35.6% | — | ||
| Q4 24 | 37.0% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 36.5% | — | ||
| Q1 24 | 36.6% | — |
营业利润率PLABRARE
| Q4 25 | — | -54.7% | ||
| Q3 25 | 22.9% | -106.9% | ||
| Q2 25 | 26.4% | -64.8% | ||
| Q1 25 | 24.6% | -102.6% | ||
| Q4 24 | 25.1% | -74.3% | ||
| Q3 24 | 24.7% | -94.6% | ||
| Q2 24 | 25.8% | -79.1% | ||
| Q1 24 | 26.6% | -151.9% |
净利率PLABRARE
| Q4 25 | — | -62.0% | ||
| Q3 25 | 10.9% | -112.8% | ||
| Q2 25 | 4.2% | -69.0% | ||
| Q1 25 | 20.2% | -108.5% | ||
| Q4 24 | 15.2% | -80.9% | ||
| Q3 24 | 16.3% | -95.7% | ||
| Q2 24 | 16.7% | -89.5% | ||
| Q1 24 | 12.1% | -156.8% |
每股收益（稀释后）PLABRARE
| Q4 25 | — | $-1.28 | ||
| Q3 25 | $0.39 | $-1.81 | ||
| Q2 25 | $0.15 | $-1.17 | ||
| Q1 25 | $0.68 | $-1.57 | ||
| Q4 24 | $0.54 | $-1.34 | ||
| Q3 24 | $0.55 | $-1.40 | ||
| Q2 24 | $0.58 | $-1.52 | ||
| Q1 24 | $0.42 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $575.8M | $421.0M |
| 总债务越低越好 | $16.0K | — |
| 股东权益账面价值 | $1.1B | $-80.0M |
| 总资产 | $1.8B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势，按日历期对齐
现金及短期投资PLABRARE
| Q4 25 | — | $421.0M | ||
| Q3 25 | $575.8M | $202.5M | ||
| Q2 25 | $558.4M | $176.3M | ||
| Q1 25 | $642.2M | $127.1M | ||
| Q4 24 | $640.7M | $174.0M | ||
| Q3 24 | $606.4M | $150.6M | ||
| Q2 24 | $559.9M | $480.7M | ||
| Q1 24 | $521.5M | $112.3M |
总债务PLABRARE
| Q4 25 | — | — | ||
| Q3 25 | $16.0K | — | ||
| Q2 25 | $19.0K | — | ||
| Q1 25 | $21.0K | — | ||
| Q4 24 | $25.0K | — | ||
| Q3 24 | $28.0K | — | ||
| Q2 24 | $2.5M | — | ||
| Q1 24 | $2.7M | — |
股东权益PLABRARE
| Q4 25 | — | $-80.0M | ||
| Q3 25 | $1.1B | $9.2M | ||
| Q2 25 | $1.1B | $151.3M | ||
| Q1 25 | $1.1B | $144.2M | ||
| Q4 24 | $1.1B | $255.0M | ||
| Q3 24 | $1.1B | $346.8M | ||
| Q2 24 | $1.0B | $432.4M | ||
| Q1 24 | $1.0B | $140.3M |
总资产PLABRARE
| Q4 25 | — | $1.5B | ||
| Q3 25 | $1.8B | $1.2B | ||
| Q2 25 | $1.7B | $1.3B | ||
| Q1 25 | $1.7B | $1.3B | ||
| Q4 24 | $1.7B | $1.5B | ||
| Q3 24 | $1.6B | $1.5B | ||
| Q2 24 | $1.6B | $1.6B | ||
| Q1 24 | $1.6B | $1.3B |
负债/权益比PLABRARE
| Q4 25 | — | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $50.1M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $25.2M | $-100.8M |
| 自由现金流率自由现金流/营收 | 12.0% | -48.6% |
| 资本支出强度资本支出/营收 | 11.8% | 0.5% |
| 现金转化率经营现金流/净利润 | 2.19× | — |
| 过去12个月自由现金流最近4个季度 | $64.5M | $-472.0M |
8季度趋势，按日历期对齐
经营现金流PLABRARE
| Q4 25 | — | $-99.8M | ||
| Q3 25 | $50.1M | $-91.4M | ||
| Q2 25 | $31.5M | $-108.3M | ||
| Q1 25 | $78.5M | $-166.5M | ||
| Q4 24 | $68.4M | $-79.3M | ||
| Q3 24 | $75.1M | $-67.0M | ||
| Q2 24 | $76.5M | $-77.0M | ||
| Q1 24 | $41.5M | $-190.7M |
自由现金流PLABRARE
| Q4 25 | — | $-100.8M | ||
| Q3 25 | $25.2M | $-92.7M | ||
| Q2 25 | $-29.1M | $-110.7M | ||
| Q1 25 | $43.3M | $-167.8M | ||
| Q4 24 | $25.2M | $-79.5M | ||
| Q3 24 | $50.7M | $-68.6M | ||
| Q2 24 | $56.5M | $-79.0M | ||
| Q1 24 | $-1.8M | $-193.9M |
自由现金流率PLABRARE
| Q4 25 | — | -48.6% | ||
| Q3 25 | 12.0% | -58.0% | ||
| Q2 25 | -13.8% | -66.5% | ||
| Q1 25 | 20.4% | -120.5% | ||
| Q4 24 | 11.3% | -48.3% | ||
| Q3 24 | 24.0% | -49.2% | ||
| Q2 24 | 26.0% | -53.7% | ||
| Q1 24 | -0.8% | -178.2% |
资本支出强度PLABRARE
| Q4 25 | — | 0.5% | ||
| Q3 25 | 11.8% | 0.8% | ||
| Q2 25 | 28.7% | 1.5% | ||
| Q1 25 | 16.6% | 1.0% | ||
| Q4 24 | 19.4% | 0.1% | ||
| Q3 24 | 11.6% | 1.2% | ||
| Q2 24 | 9.2% | 1.4% | ||
| Q1 24 | 20.0% | 3.0% |
现金转化率PLABRARE
| Q4 25 | — | — | ||
| Q3 25 | 2.19× | — | ||
| Q2 25 | 3.55× | — | ||
| Q1 25 | 1.83× | — | ||
| Q4 24 | 2.02× | — | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.11× | — | ||
| Q1 24 | 1.59× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PLAB
| High End Integrated Circuits | $53.6M | 25% |
| High End Flat Panel Displays | $53.5M | 25% |
| KR | $43.7M | 21% |
| Other | $42.1M | 20% |
| Mainstream Flat Panel Displays | $9.1M | 4% |
| Transferred At Point In Time | $8.4M | 4% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
